240
Participants
Start Date
March 31, 2004
STR(TM) (Skeletal Targeted Radiotherapy, Holmium-166-DOTMP)
Montefiore Medical Center, The Bronx
University of Pennsylvania, Philadelphia
Virginia Commonwealth University, Richmond
Duke University Medical Center, Durham
Winship Cancer Institute of Emory University, Atlanta
University of Miami, Miami
University of Alabama, Birmingham
Vanderbilt University Medical Center, Nashville
Case Western Reserve University, Cleveland
Miami Valley Hospital, Dayton
Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit
University of Iowa Hospital and Clinics, Iowa City
Medical College of Wisconsin, Milwaukee
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
Baylor University Medical Center, Dallas
MD Anderson Cancer Center, Houston
Rocky Mountain Cancer Centers, Denver
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Fred Hutchinson Cancer Research Center, Seattle
Princess Margaret Hospital, Toronto
Lead Sponsor
Poniard Pharmaceuticals
INDUSTRY